Analyst Recommendations

UBS analyst issues BUY recommendation for MRVL on May 26, 2026 01:34PM ET. The previous analyst recommendation was Buy.MRVL was trading at $209.44 at issue of the analyst...

May 26, 2026   MRVL -3.07%

Barclays analyst issues POSITIVE recommendation for MRVL on May 26, 2026 01:34PM ET. The previous analyst recommendation was Overweight.MRVL was trading at $209.44 at issue of the analyst...

May 26, 2026   MRVL -3.07%

KeyBanc analyst issues SECTOR WEIGHT recommendation for MRVL on May 26, 2026 01:34PM ET. The previous analyst recommendation was Overweight.MRVL was trading at $209.44 at issue of the...

May 26, 2026   MRVL -3.07%

Barclays analyst issues OVERWEIGHT recommendation for COP on May 26, 2026 11:24AM ET. The previous analyst recommendation was Overweight.COP was trading at $120.46 at issue of the analyst...

May 26, 2026   COP 0.94%

Barclays analyst issues OVERWEIGHT recommendation for DVN on May 26, 2026 11:24AM ET. The previous analyst recommendation was Overweight.DVN was trading at $47.22 at issue of the analyst...

May 26, 2026   DVN 0.50%

Cantor Fitzgerald analyst issues NEUTRAL recommendation for MRVL on May 26, 2026 11:29AM ET. The previous analyst recommendation was Neutral.MRVL was trading at $196.33 at issue of the...

May 26, 2026   MRVL -3.07%

Barclays analyst issues OVERWEIGHT recommendation for XOM on May 26, 2026 11:25AM ET. The previous analyst recommendation was Overweight.XOM was trading at $154.92 at issue of the analyst...

May 26, 2026   XOM 1.03%

HSBC analyst issues BUY recommendation for MRVL on May 26, 2026 11:55AM ET. The previous analyst recommendation was Hold.MRVL was trading at $196.33 at issue of the analyst...

May 26, 2026   MRVL -3.07%

Susquehanna analyst issues POSITIVE recommendation for MRVL on May 26, 2026 11:52AM ET. The previous analyst recommendation was Positive.MRVL was trading at $196.33 at issue of the analyst...

May 26, 2026   MRVL -3.07%

Jefferies analyst issues BUY recommendation for CRM on May 26, 2026 09:56AM ET. The previous analyst recommendation was Buy.CRM was trading at $180.07 at issue of the analyst...

May 26, 2026   CRM 0.50%